相关实验视频

Updated: May 27, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

移植后早期对肺抗原的幽默免疫力会导致慢性肺异位移植功能障碍的风险

Daniel Vosoughi¹, Ambily Ulahannan², Qixuan Li³

¹Latner Thoracic Research Laboratories, University Health Network, Toronto, Ontario, Canada; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

|February 19, 2025

概括

新型自身抗体和新的捐赠者HLA特异性抗体 (dnDSA) 与慢性肺异位移植功能障碍 (CLAD) 有关. 特定的自身抗体配置文件可以预测肺移植接受者的CLAD风险或保护.

科学领域:

免疫学免疫学免疫学
移植移植移植移植
这是一种自身免疫力.

背景情况:

慢性肺异位移植功能障碍 (CLAD) 是肺移植后的一个主要并发症.
自体抗体和新捐赠者HLA特异性抗体 (dnDSA) 在CLAD病原发生中的作用尚未完全理解.
自抗原反应的范围及其与CLAD的关联需要进一步研究.

研究的目的:

查肺移植接受者是否有新型自身抗体,并评估它们与CLAD.的关联.
评估新捐赠者HLA特异性抗体 (dnDSA) 对CLAD发育的影响.
为了识别预测CLAD风险或保护的自身抗体特征.

主要方法:

分析了89名双边肺移植接受者的血清样本.
在移植和移植后6个月使用定制抗原微阵列进行了自身抗体查.
评估了新的捐赠者HLA特异性抗体 (dnDSA) 暴露和无CLAD存活率.

主要成果:

患有CLAD的患者在移植后6个月显示IgG反应性下降,但IgM反应性没有变化.
移植后6个月对热素,SP-D和甲状腺蛋白的IgG自身抗体升高与CLAD的发展有关.
较高的抗CENP-B和PM/SCL100的IgG与无CLAD存活率相关,这表明IgG具有保护作用.

结论:

新型自身抗体独立地与肺移植患者的CLAD和CLAD无生存相关.
特定的自身抗体配置文件可以显著增加CLAD风险.
针对肺丰富抗原和dndsa的自身抗体之间的相互作用可能通过特定组织机制放大clad的发展.

关键词:

抗体是一种抗体.慢性肺病是一种慢性肺病.肺部移植肺部移植微阵列是一个微阵列.血液中的血清是血清.

更多相关视频

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...